Form 4 for PFE Pfizer
Accepted 2024-06-03 00:00:00 ET · period of report 2024-05-31 · accession 0001225208-24-006527 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-03 | 2024-05-31 | PFE | Denton David M | CFO, EVP | F - Tax | $28.66 | -12.1K | 37.9K | -24% | -$347.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | F | D | 12,107 | $28.66 | 37,919 | D | — | — | (F1) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |